The DOI matches its Crossref record; 199 of the 199 references it cites were found in a registry or an index.
The molecular role of Myc in growth and transformation: recent discoveries lead to new insights
Abstract
A major dilemma facing the Myc researcher is understanding how c‐Myc regulation of gene transcription translates into the proliferative and oncogenic activities mediated by c‐Myc protein. Indeed, much effort has focused on attempting to link c‐Myc activation of gene transcription with both cell cycle progression and transformation mechanisms. Considerable progress has been made in recent years, with the identification of new Myc binding proteins as well as novel cellular targets of Myc‐Max complexes. These discoveries have yielded more than a few surprises and challenged those working in the field to rethink traditional paradigms. It is now evident that c‐Myc can also repress the transcription of specific genes, and Myc‐mediated repression appears to be linked to Myc‐dependent transformation. We summarize the evidence on Myc biological and molecular functions with regard to Myc‐Max transcriptional regulation. In addition, we reevaluate current models of Myc transcriptional modulation in light of the discovery of new Myc binding partners and novel downstream target genes. Finally, we explore whether direct transactivation of cellular genes by Myc‐Max heterodimers is sufficient for the growth‐promoting and transforming activities of Myc or whether other molecular activities of Myc, such as Myc‐mediated repression, may play a key role.—Facchini, L. M., Penn, L. Z. The molecular role of Myc in growth and transformation: recent discoveries lead to new insights. FASEB J. 12, 633–651 (1998)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,935
Self-citationTumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804 · cited 1×
“In primary rat embryo fibroblasts and hematopoietic cells, constitutive expression of c-myc, along with a cooperating oncogene such as ras or vabl, results in malignant transformation (48, 49).”
BackgroundCell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor
Kelly, K., Cochran, B. H., Stiles, C. D., & Leder, P. (1983) · Cell · doi:10.1016/0092-8674(83)90092-2 · Cited by 2,296
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
Adams, J. M., Harris, A. W., Pinkert, C. A., Corcoran, L. M., Alexander, W. S., Cory, S., Palmiter, R. D., & Brinster, R. L. (1985) · Nature · doi:10.1038/318533a0 · Cited by 1,779
Max: A Helix-Loop-Helix Zipper Protein That Forms a Sequence-Specific DNA-Binding Complex with Myc
Blackwood, E. M., & Eisenman, R. N. (1991) · Science · doi:10.1126/science.2006410 · Cited by 1,697
Ruley, H. E. (1983) · Nature · doi:10.1038/304602a0 · Cited by 1,248
Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB
Kauffmann-Zeh, A., Rodriguez-Viciana, P., Ulrich, E., Gilbert, C., Coffer, P., Downward, J., & Evan, G. (1997) · Nature · doi:10.1038/385544a0 · Cited by 1,148
c-Myc transactivation of LDH-A : Implications for tumor metabolism and growth
Shim, H., Dolde, C., Lewis, B. C., Wu, C.-S., Dang, G., Jungmann, R. A., Dalla-Favera, R., & Dang, C. V. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6658 · Cited by 1,092
Apoptotic cell death induced by c-myc is inhibited by bcl-2
Bissonnette, R. P., Echeverri, F., Mahboubi, A., & Green, D. R. (1992) · Nature · doi:10.1038/359552a0 · Cited by 957
Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap
Lazaris-Karatzas, A., Montine, K. S., & Sonenberg, N. (1990) · Nature · doi:10.1038/345544a0 · Cited by 956
Cited by
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
Massagué, J., Blain, S. W., & Lo, R. S. (2000) · Cell · doi:10.1016/s0092-8674(00)00121-5 · Cited by 2,385
Siddiqui-Jain, A., Grand, C. L., Bearss, D. J., & Hurley, L. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182256799 · Cited by 2,238
Helix-Loop-Helix Proteins: Regulators of Transcription in Eucaryotic Organisms
Massari, M. E., & Murre, C. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.2.429-440.2000 · Cited by 1,816
c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism
Dang, C. V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.1 · Cited by 1,715
Reflecting on 25 years with MYC
Meyer, N., & Penn, L. Z. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2231 · Cited by 1,575
“Phosphopeptide analysis revealed that specific serine and threonine residues of MYC were phosphorylated in vivo (reviewed in Ref”
BackgroundSelf-citationTranscriptional Amplification in Tumor Cells with Elevated c-Myc
Lin, C. Y., Lovén, J., Rahl, P. B., Paranal, R. M., Burge, C. B., Bradner, J. E., Lee, T. I., & Young, R. A. (2012) · Cell · doi:10.1016/j.cell.2012.08.026 · Cited by 1,513
The Myc/Max/Mad Network and the Transcriptional Control of Cell Behavior
Grandori, C., Cowley, S. M., James, L. P., & Eisenman, R. N. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.653 · Cited by 1,333
Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF
Jacobs, J. J. L., Scheijen, B., Voncken, J.-W., Kieboom, K., Berns, A., & van Lohuizen, M. (1999) · Genes & Development · doi:10.1101/gad.13.20.2678 · Cited by 1,065
Reversible Tumorigenesis by MYC in Hematopoietic Lineages
Felsher, D. W., & Bishop, J. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80367-6 · Cited by 881
Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells
Elenbaas, B., Spirio, L., Koerner, F., Fleming, M. D., Zimonjic, D. B., Donaher, J. L., Popescu, N. C., Hahn, W. C., & Weinberg, R. A. (2001) · Genes & Development · doi:10.1101/gad.828901 · Cited by 878
MicroRNA Let-7a Down-regulates MYC and Reverts MYC-Induced Growth in Burkitt Lymphoma Cells
Sampson, V. B., Rong, N. H., Han, J., Yang, Q., Aris, V., Soteropoulos, P., Petrelli, N. J., Dunn, S. P., & Krueger, L. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2462 · Cited by 805
Chang, F., Steelman, L. S., Lee, J. T., Shelton, J. G., Navolanic, P. M., Blalock, W. L., Franklin, R. A., & McCubrey, J. A. (2003) · Leukemia · doi:10.1038/sj.leu.2402945 · Cited by 725
Genome-Wide Analysis of Basic/Helix-Loop-Helix Transcription Factor Family in Rice and Arabidopsis
Li, X., Duan, X., Jiang, H., Sun, Y., Tang, Y., Yuan, Z., Guo, J., Liang, W., Chen, L., Yin, J., et al. (2006) · Plant Physiology · doi:10.1104/pp.106.080580 · Cited by 701
Ambrus, A., Chen, D., Dai, J., Jones, R. A., & Yang, D. (2005) · Biochemistry · doi:10.1021/bi048242p · Cited by 683
Jonas, J.-C., Sharma, A., Hasenkamp, W., Ilkova, H., Patanè, G., Laybutt, R., Bonner-Weir, S., & Weir, G. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.20.14112 · Cited by 559
Knoepfler, P. S., Cheng, P. F., & Eisenman, R. N. (2002) · Genes & Development · doi:10.1101/gad.1021202 · Cited by 519
The pleiotropic functions of the Y‐box‐binding protein, YB‐1
Kohno, K., Izumi, H., Uchiumi, T., Ashizuka, M., & Kuwano, M. (2003) · BioEssays · doi:10.1002/bies.10300 · Cited by 502
The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc
McMahon, S. B., Wood, M. A., & Cole, M. D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.2.556-562.2000 · Cited by 494
“Since Myc-Max and Mad-Max dimers are reported to have indistinguishable DNA binding specificities (1, 50), current models suggest that repression of c-Myc function by the Mad-Max-mSin3-HDAC complex results from the deacetylation of nucleosomal histones at shared target sites within the genome (12).”
BackgroundTGFβ influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b
Seoane, J., Pouponnot, C., Staller, P., Schader, M., Eilers, M., & Massagué, J. (2001) · Nature Cell Biology · doi:10.1038/35070086 · Cited by 489
Phosphorylation by Glycogen Synthase Kinase-3 Controls c-Myc Proteolysis and Subnuclear Localization
Gregory, M. A., Qi, Y., & Hann, S. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m310722200 · Cited by 475
Gregory, M. A., & Hann, S. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.7.2423-2435.2000 · Cited by 469
The myc Oncogene: arvelouslomplex
(2002) · Advances in Cancer Research · doi:10.1016/s0065-230x(02)84004-0 · Cited by 463
Beta-cell adaptation and decompensation during the progression of diabetes
Weir, G. C., Laybutt, D. R., Kaneto, H., Bonner-Weir, S., & Sharma, A. (2001) · Diabetes · doi:10.2337/diabetes.50.2007.s154 · Cited by 462
Vermeulen, K., Berneman, Z. N., & Van Bockstaele, D. R. (2003) · Cell Proliferation · doi:10.1046/j.1365-2184.2003.00267.x · Cited by 461
The Basic Helix-Loop-Helix Protein Family: Comparative Genomics and Phylogenetic Analysis
Ledent, V., & Vervoort, M. (2001) · Genome Research · doi:10.1101/gr.177001 · Cited by 458
Qin, Y., & Hurley, L. H. (2008) · Biochimie · doi:10.1016/j.biochi.2008.02.020 · Cited by 450
Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP
Kung, A. L., Rebel, V. I., Bronson, R. T., Ch'ng, L.-E., Sieff, C. A., Livingston, D. M., & Yao, T.-P. (2000) · Genes & Development · doi:10.1101/gad.14.3.272 · Cited by 440
Mechanisms of apoptosis by c-Myc
Prendergast, G. C. (1999) · Oncogene · doi:10.1038/sj.onc.1202727 · Cited by 430
Analysis of C-MYC Function in Normal Cells via Conditional Gene-Targeted Mutation
de Alboran, I. M., O'Hagan, R. C., Gärtner, F., Malynn, B., Davidson, L., Rickert, R., Rajewsky, K., DePinho, R. A., & Alt, F. W. (2001) · Immunity · doi:10.1016/s1074-7613(01)00088-7 · Cited by 398
c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function
Cheng, S.-W. G., Davies, K. P., Yung, E., Beltran, R. J., Yu, J., & Kalpana, G. V. (1999) · Nature Genetics · doi:10.1038/8811 · Cited by 396
The Dynamic Character of the G-Quadruplex Element in the c-MYC Promoter and Modification by TMPyP4
Seenisamy, J., Rezler, E. M., Powell, T. J., Tye, D., Gokhale, V., Joshi, C. S., Siddiqui-Jain, A., & Hurley, L. H. (2004) · Journal of the American Chemical Society · doi:10.1021/ja040022b · Cited by 389
Liao, D. J., & Dickson, R. B. (2000) · Endocrine-related cancer · doi:10.1677/erc.0.0070143 · Cited by 343
N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation
Malynn, B. A., de Alboran, I. M., O'Hagan, R. C., Bronson, R., Davidson, L., DePinho, R. A., & Alt, F. W. (2000) · Genes & Development · doi:10.1101/gad.14.11.1390 · Cited by 335
Biomolecular Condensates and Cancer
Boija, A., Klein, I. A., & Young, R. A. (2021) · Cancer Cell · doi:10.1016/j.ccell.2020.12.003 · Cited by 327
Chen, C.-R., Kang, Y., & Massagué, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.992 · Cited by 320
Seenisamy, J., Bashyam, S., Gokhale, V., Vankayalapati, H., Sun, D., Siddiqui-Jain, A., Streiner, N., Shin-ya, K., White, E., Wilson, W. D., et al. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0444482 · Cited by 319
The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation
Cole, M. D., & McMahon, S. B. (1999) · Oncogene · doi:10.1038/sj.onc.1202748 · Cited by 314
FOXM1, a typical proliferation-associated transcription factor
Wierstra, I., & Alves, J. (2007) · bchm · doi:10.1515/bc.2007.159 · Cited by 313
Stabilization of G-Quadruplex DNA and Down-Regulation of Oncogene c-myc by Quindoline Derivatives
Ou, T.-M., Lu, Y.-J., Zhang, C., Huang, Z.-S., Wang, X.-D., Tan, J.-H., Chen, Y., Ma, D.-L., Wong, K.-Y., Tang, J. C.-O., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0610088 · Cited by 288
Targeting Stat3 in cancer therapy
Jing, N., & Tweardy, D. J. (2005) · Anti-Cancer Drugs · doi:10.1097/00001813-200507000-00002 · Cited by 278
Repression of transcription of the p27Kip1 cyclin-dependent kinase inhibitor gene by c-Myc
Yang, W., Shen, J., Wu, M., Arsura, M., FitzGerald, M., Suldan, Z., Kim, D. W., Hofmann, C. S., Pianetti, S., Romieu-Mourez, R., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204245 · Cited by 277
Genome-wide identification and characterization of the bHLH gene family in tomato
Sun, H., Fan, H.-J., & Ling, H.-Q. (2015) · BMC Genomics · doi:10.1186/s12864-014-1209-2 · Cited by 261
Claassen, G. F., & Hann, S. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150006697 · Cited by 256
The c‐myc Promoter: Still MysterY and Challenge
(2008) · Advances in Cancer Research · doi:10.1016/s0065-230x(07)99004-1 · Cited by 211
Laybutt, D. R., Weir, G. C., Kaneto, H., Lebet, J., Palmiter, R. D., Sharma, A., & Bonner-Weir, S. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1793 · Cited by 144
The tale of transforming growth factor‐beta (TGFβ) signaling: A soigné enigma
Chaudhury, A., & Howe, P. H. (2009) · IUBMB Life · doi:10.1002/iub.239 · Cited by 105
Pereira, M. A. (2001) · Carcinogenesis · doi:10.1093/carcin/22.9.1511 · Cited by 61
CIP2A is a predictor of survival and a novel therapeutic target in bladder urothelial cell carcinoma
Xue, Y., Wu, G., Wang, X., Zou, X., Zhang, G., Xiao, R., Yuan, Y., Long, D., Yang, J., Wu, Y., et al. (2013) · Medical Oncology · doi:10.1007/s12032-012-0406-6 · Cited by 34
Metadata
- Authors
- Facchini, L. M., & Penn, L. Z.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 1998-06
- Volume
- 12
- Issue
- 9
- Pages
- 633-651
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1953035097
- Cited by
- 377
- References
- 199
- FWCI
- 17.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.